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52 The Journal of Thoracic and Cardiobjectives: We report our experience with extracorporeal cardiopulmonary resus-
itation with extracorporeal membrane oxygenation in children having cardiac arrest
efractory to conventional cardiopulmonary resuscitation and explore predictors for
avorable outcome (survival with grossly intact neurologic status).
ethods: We reviewed all patients who required extracorporeal cardiopulmonary
esuscitation from 2000 to 2005. Multivariable regression analysis determined
actors associated with favorable outcome and time-related survival.
esults: Eighty children, median age 150 days (range: 1 day–17.6 years), required
enoarterial extracorporeal cardiopulmonary resuscitation. There were several cat-
gories of disease among the patients: postcardiotomy (n  39), unoperated con-
enital heart disease (n 17), cardiomyopathy (n 12), respiratory failure (n 9),
r myocarditis (n  3). Cannulation sites were neck (n  45) or chest (n  36).
edian duration of extracorporeal membrane oxygenation was 4 days (range:
–22). Extracorporeal membrane oxygenation was successfully discontinued in 42
54%) patients: wean (n  35), heart transplantation (n  7). Survival till hospital
ischarge was 27 (34%) patients. Most common cause of death was ischemic brain
njury (n  17). Twenty-four (30%) patients had a favorable outcome. Median
uration of cardiopulmonary resuscitation for patients with favorable versus unfa-
orable outcome was 46 minutes (range: 14–95; interquartile range: 29–55) versus
1 minutes (range: 19–110; interquartile range: 30–55), P .916. According to the
ogistic regression model, none of the following factors was a significant predictor
f favorable outcome: age, weight, sex, etiology (cardiac vs noncardiac), duration of
ardiopulmonary resuscitation, cannulation site, timing, or location of extracorpo-
eal membrane oxygenation institution.
onclusions: Acceptable survival and neurologic outcomes (30%) can be achieved
ith extracorporeal cardiopulmonary resuscitation in children after prolonged car-
iac arrest (up to 95 minutes) refractory to conventional resuscitation measures.
eart transplantation is often needed for successful extracorporeal cardiopulmonary
esuscitation exit strategy. Lack of predictors of poor outcome support aggressive
ttempts to initiate extracorporeal cardiopulmonary resuscitation in all patients,
ollowed by subsequent assessment of organ salvage.
n-hospital cardiac arrest is associated with high mortality and subsequent
morbidity in surviving children.1-9 Additionally, increased duration of cardio-
pulmonary resuscitation (CPR) is associated with higher mortality and perma-
ent central nervous system damage. After CPR duration lasting more than 30
inutes, survival with conventional CPR measures ranges between 0% and 5%.1,2
vascular Surgery ● October 2007
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DExtracorporeal cardiopulmonary resuscitation (ECPR) is
he rapid deployment of extracorporeal membrane oxygen-
tion (ECMO) to provide immediate cardiovascular support
or patients who have cardiac arrest unresponsive to con-
entional CPR measures.2,9-18
Several case series reported the use of ECPR in pediatric
nd adult cardiac patients, with a rate of survival to hospital
ischarge of 30% to 80%.2,9-18 The use of ECPR in cardiac
rrest for noncardiac medical conditions has been reported
ess frequently and has been associated with worse out-
ome.2 Several series reported that mechanical assistance
ith ECMO in children having cardiac arrest refractory to
onservative CPR measures is a significant factor for im-
roved survival.1-9 Survival may vary between different
rograms on the basis of patient selection and the capability
o institute ECMO in a timely fashion. Since 2000, we have
stablished a rapid resuscitation ECMO program at the
ospital for Sick Children in Toronto using a preassembled
nd preprimed ECMO circuit. The aim of this program is to
e-establish cardiac output and organ perfusion and to pre-
ent permanent end-organ injury while awaiting reversal of
ardiac and other organ disease process or as a bridge to
eart transplantation.
In this current series, we report our experience with
CPR over the past 5 years and explore predictors for
avorable patient outcome, defined as hospital survival with
rossly intact neurologic status.
atients and Methods
pproval of this study was obtained from the Research Ethics
oard at the Hospital for Sick Children in Toronto. From March
000 to December 2005, 80 children less than 18 years of age
equired ECPR. Patients were included in the ECPR group if
enoarterial ECMO was used as part of the initial active resusci-
ation from a cardiac arrest. Patients who were in hemodynami-
ally unstable condition and placed on ECMO urgently without
ctive cardiac arrest were not included in this study.
Patients were identified according to the institutional ECMO
nd Surgical Database. Clinical, operative, and outcome data were
bstracted from the medical records. Risk factors available before
he start of ECPR were analyzed.
CMO Circuit and Equipment
preassembled and preprimed ECMO circuit and trained personal
Abbreviations and Acronyms
CCU  critical care unit
CPR  cardiopulmonary resuscitation
ECMO extracorporeal membrane oxygenation
ECPR  extracorporeal cardiopulmonary resuscitation
IQR  interquartile range
OHTX  orthotopic heart transplantationre available in the critical care unit (CCU) at all times. c
The Journal of ThoracicThe circuit is composed of ¼-inch internal diameter polyvinyl
hloride tubing with Carmeda (Medtronic, Minneapolis, Minn)
eparin-bonded biocompatible surface coating. The total prime is
pproximately 400 mL. The main components are the Jostra Ro-
aflow centrifugal pump (Maquet, Hirrlingen, Germany) and Hilite
400 LT oxygenator (Medos, Stolberg, Germany) (Figure E1).
his system can support patients up to 20 kg and will provide
emporary support for larger patients until a 3/8-inch circuit with
n increased surface area oxygenator can be substituted. The
ircuit is primed with PlasmaLyte 148 (Baxter Corp, Toronto,
ntario, Canada), an unbuffered electrolyte solution, and is usable
or 30 days. This safe limit has been determined by multiple
eriodic sterility testing of prime fluid with aerobic, anaerobic, and
ungus cultures, and none of those cultures was positive up to 30
ays.
Once ECPR is required, a predefined protocol is initiated. The
ircuit and all necessary ancillary equipment are brought to the
edside, creating a mini operating room setting in the CCU. A
urgical table with sterile ECMO instrument tray, a single bundle
f disposable and reusable equipment, a full cannulation cart with
annula size and flow guidelines, emergency albumin, cautery, and
eadlight are exclusively available to the rescue ECMO program
nd housed in the CCU.
All cannulations at our institution are performed by a staff
ardiac surgeon or with a staff cardiac surgeon assisting. Cannu-
ation site is dependent on the clinical situation. In postcardiotomy
atients having postoperative cardiac arrest within the first week
fter surgery, direct aortic and atrial cannulation through the chest
s usually done inasmuch as it provides the most expeditious
eans of instituting support while allowing the performance of
ffective open CPR. In patients who have cardiac arrest in settings
ther than the early postoperative period, neck cannulation is
erformed in our series of patients. Femoral cannulation can be
onsidered as an alternative peripheral cannulation site in older
hildren and adults.
When ECPR is requested, the blood bank is notified to prepare
lood products. However, owing to time limitations, it is often
ecessary to initiate ECMO support with a clear prime. Heparin 1
/mL of prime, sodium bicarbonate 15 mEq, and calcium chloride
50 mg are added to the prime before cannulation. Additionally,
ystemic heparin is administered at a dose of 50 U/kg body weight
o maintain an activated clotting time of 180 to 200 seconds.
Once the patient’s condition is stable on ECMO, the crystalloid
olume is removed and packed red blood cells are added by a
ne-for-one syringe exchange transfusion process. Platelets and
ryoprecipitate are given to correct the inherent coagulation defi-
iency. For children less than 1 year of age, an infusion of fresh
rozen plasma is placed in the circuit at 20 mL/kg every 8 hours.
he administration of blood products continues until transfusion
argets are reached: hemoglobin 110 g/L, platelet count 100,000/
m3, fibrinogen 2 g/L, and antithrombin 1 U/mL.
escue ECMO Team
he success of an ECPR program is dependent on the quick
esponse of a team of specifically skilled and trained professionals.
ndividual roles and responsibilities have been identified so that
he process can be expedited. A certified ECMO specialist and/or
ardiovascular perfusionist are available in-house at all times. The
and Cardiovascular Surgery ● Volume 134, Number 4 953
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Dther members of the team include the CCU attending physician/
ellow, cardiovascular staff surgeon and fellow, and cardiac nurse.
dditional professional support is provided by cardiology, hema-
ology, respiratory therapy, blood bank, laboratory medicine, and
ocial work.
Registered respiratory therapists and registered nurses enroll in
n in-house ECMO training program that consists of a didactic
omponent, wet laboratory simulation, and animal laboratory man-
gement sessions. The ECMO specialist must then attain 100
edside clinical hours. A written examination and subsequent oral
nd practical evaluation are completed before certification is
warded.
To increase proficiency and accuracy of the team, and to
dentify any system deficits to improve the ECPR process and
inimize response times in critical situations, an intensivist and a
enior perfusionist periodically perform random mock rescue
CMO drills, done without warning, in the intensive care unit.
CU Management
he pump flow is started initially at 100 mL · kg1 · min1 and
djusted to maintain end-organ perfusion, normalization of arterial
lood gases, increase in systemic venous saturation, and clearance
f lactic acidosis. Higher flows are needed for infants with single
entricle and an open modified Blalock–Taussig shunt. Cardiac
notropic agents are maintained and adjusted as needed to maintain
eft heart function and pulsatility. Vasopressors are used to main-
ain a mean blood pressure of around 60 mm Hg. Afterload-
educing agents such as phenoxybenzamine and nitroprusside are
ften used to improve cardiac performance. Similarly, nitric oxide
Inotherapeudics, Clinton, NJ), beginning at 20 to 40 ppm and
eaned according to protocol, is used in children with refractory
ulmonary hypertension. Mechanical ventilation rate is adjusted to
aintain oxygenation of blood generated by the native cardiac
utput and to prevent lung atelectasis. The usual ventilations rate
s 10 to 12 breaths/min, with an inspired oxygen fraction of 0.21
o 0.35 and the peak inspiratory pressure maintained under
0 cm H2O.
After establishment of ECMO, the consciousness level is eval-
ated every 12 hours after ECPR, aiming to identify persistent
evere neurologic insult requiring withdrawal of ECMO support.
ore recently, mild hypothermic core cooling and application of
ce to the patient’s head have been used for up to 48 hours after
ardiac arrest in an effort to lower metabolic demands as part of a
rospectively randomized study to minimize postarrest neurologic
nsult. Future follow-up and analysis of this study is needed to
onfirm the benefit of that practice.
Assessment of the underlying cause leading to cardiac arrest is
egun soon after patient stabilization, and further intervention is
onsidered to address and treat the underlying cause and optimize
he patient for future weaning.
In patients who have had cardiac arrest, follow-up echocardi-
graphy is done up to a daily interval to estimate the recovery of
he heart, detect residual lesions and thrombus formation in the left
entricle, and to assess the need for heart transplantation in case of
ailure of heart recovery. Timing of weaning is dependent on the
linical scenario, hemodynamic stability during ECMO support,
orrection of the underlying cause, and the presence of residual
esions. c
54 The Journal of Thoracic and Cardiovascular Surgery ● OctoIn general, weaning for postcardiotomy patients is begun
round 72 hours after ECMO support. Transesophageal echocar-
iography is frequently used to assess myocardial function during
he weaning process.
Weaning and separation from ECMO assist is accomplished
ith optimal ventilator and inotropic support, preferably with an
pinephrine requirement of 0.05 g · kg1 · min1 or less. ECMO
ow rates are gradually decreased. When flow rates are approxi-
ately 25% of maximal support, the bridge between the arterial
nd venous systems is unclamped and the circuit allowed to
ecirculate.
After successful separation from ECMO, the cannulas are usu-
lly left in place for 1 to 3 hours, flushed every 10 to 15 minutes,
nd subsequently removed if hemodynamic stability is maintained.
urse-string sutures are usually left in place and resnared with the
hest left open after cannula removal in all postcardiotomy pa-
ients. In patients who have had neck cannulation, the vessels are
epaired if the tissue was of good quality and the patient required
week of ECMO support or less.
tatistical Analysis
escriptive statistics were reported as median, range, and inter-
uartile range (IQR) for continuous variables and as frequencies
nd percentages for categorical variables. Unrelated 2-group com-
arisons were done with unpaired, 2-tailed t tests for continuous
ariables and the 2 or Fisher exact test for categorical data.
otential risk factors that were available before the institution of
CPR were analyzed with a multivariable logistic regression
odel. The response variable was death or gross neurologic deficit
ithin admission. Long-term time-related survival and freedom
rom morbid events were estimated by the Kaplan–Meier method.
ultivariable Cox regression was used to determine the indepen-
ent predictors of time-related survival. In all multivariable mod-
ls, the normality and linearity of continuous variables was as-
essed and appropriate transformations were used where
ecessary. All analyses were done with the R statistical package.
esults
atients Characteristics
total of 80 patients (47 boys) required ECPR during
ctive cardiac massage. Patients ranged in age from 1 day to
7.6 years, with a median age of 150 days (IQR: 24–787).
edian weight was 5.2 kg (range: 1.7-90; IQR: 3.2–10.1)
ost patients had cardiac disease (n  71) including post-
ardiotomy cardiac arrest (n  39), unoperated congenital
eart disease (n  17), cardiomyopathy (n  12), and
yocarditis (n 3). The remaining patients had noncardiac
roblems (n 9) including meconium aspiration syndrome,
ongenital diaphragmatic hernia, drowning, lamp oil aspi-
ation, thoracic lymphoma, pulmonary embolus, adenovirus
nfection, pneumonia, and complications after adenoidec-
omy (n  1 each).
ECPR was initiated in the CCU in the majority of the
ases (n  71), followed by the catheterization laboratory
n  6) and the operating room (n  3). Children having
ardiac arrest in the emergency room or the regular ward
ber 2007
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Dere promptly transferred to the CCU after initiation of
PR so that ECPR could be started in the CCU. The timing
f ECPR initiation was during weekdays (8 AM–5 PM) (n 
5), weekends (n  18), and weeknights (5 PM–8 AM) (n 
4). Cannulation sites were intrathoracic in 35 patients,
eck cannulation in 44 patients, and both neck and intratho-
acic cannulation in 1 patient owing to inadequate flows
fter neck ECMO. The median interval between the begin-
ing of CPR and the initiation of ECMO (CPR duration)
as 41 minutes (range: 14–110; IQR: 30–55; mean  SD
44  19). The complete demographic data for all the
atients treated with ECPR are listed in Table 1.
arly Results
CMO was successfully discontinued (ie, children were
ble to maintain adequate hemodynamics 24 hours after
CMO discontinuation) in 42 (53%) patients. This was
ccomplished by successful weaning (n  35) or by ortho-
opic heart transplantation (n  7). Twenty-seven (34%)
atients survived to hospital discharge. The causes for mor-
ality included ischemic brain injury (n  17, 32% of
eaths), multiorgan failure (n 13, 25%), failure of cardiac
ecovery (n  11, 21%), sepsis (n  7, 13%), and intra-
entricular hemorrhage (n  5, 9%). Twenty-four (30%)
atients had favorable outcome (hospital survival with
ABLE 1. Descriptive statistics for patients with cardiac a
Cardiac disease (n  71)
ge (mo) 4.9 (0.8–17.1)
eight (kg) 4.8 (3.2–10)
ex
Female 38%
Male 62%
annulation site
Thoracic 49%
Neck 51%
CPR location
ICU 87%
Cath lab 8%
OR 4%
CPR timing
Weekday 35%
Weeknight 41%
Weekend 25%
natomy precluding effective CPR 4%
CMO exit by heart transplantation 11%
re-ECMO CPR duration (min) 42 (30–55)
CMO duration (d) 4 (2.5–8)
ospital survivor 37%
avorable outcome 32%
ontinuous variables presented as median (25th quartile-75th quartile). ECP
ab, catheterization laboratory; OR, operating room; CPR, cardiopulmonaryrossly intact neurologic status). The median ECMO dura- I
The Journal of Thoracicion for the whole group was 4 days (range: 1–22; IQR:
–8).
isk Factors for Unfavorable Outcome
ariables available before initiation of ECPR were analyzed
o test whether or not they were significant predictors of an
nfavorable outcome. Those factors included the age,
eight, and sex of the patients; the location and timing of
CPR initiation; the cannulation site; the underlying cardiac
tiology; the presence of factors that would prevent effec-
ive CPR, such as blocked aortopulmonary shunts or dis-
odged interventional Fontan stents placed in the catheter-
zation laboratory; and finally CPR duration before ECMO
nitiation and the duration of ECMO. None of those
actors was significantly different between the 2 groups
Table 2), and none was found to be independently pre-
ictive of an unfavorable outcome by multivariable re-
ression (Table E1).
Of special interest, the median CPR duration before
CMO initiation for patients with favorable versus unfa-
orable outcome was 46 minutes (range: 14–95; IQR: 29–
5) versus 41 minutes (range: 19-110; IQR: 30–55), P .9.
Figure 1). Moreover, median duration of ECMO for pa-
ients with favorable versus unfavorable outcome was 4
ays (range: 1–18; IQR: 3–6) versus 4 days (range: 1–22;
oncardiac underlying pathologic conditions
Noncardiac disease (n  9) All patients (n  80) P value
25.4 (1.9–127.6) 4.9 (0.8–25.8) .3
13.9 (3.1–41.3) 5.2 (3.2–10.1) .3
67% 41% .1
33% 59%
11% 45% .5
89% 55%
100% 89% .5
0% 8%
0% 4%
12% 32% .03
75% 44%
12% 23%
0% 4% .5
0% 10% .3
41 (39–50) 41 (30–55) .6
1 (1–4) 4 (2–8) .09
11% 34% .1
11% 30% .2
tracorporeal cardiopulmonary resuscitation; ICU, intensive care unit; Cath
scitation; ECMO, extracorporeal membrane oxygenation.nd n
R, exQR: 2–8), P  .9 (Figure E2).
and Cardiovascular Surgery ● Volume 134, Number 4 955
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Dime-related Survival Results
ime-related survival at 1 and 3 years was 29% and 27%,
espectively (Figure E3). On multivariable analysis, none of
he studied variables was a significant risk factor for dimin-
shed survival (Table E2).
iscussion
lthough the use of ECMO support to treat pediatric pa-
ients with cardiac arrest refractory to routine resuscitation
easures has been reported by several centers, little infor-
ation exists regarding the outcome predictors of this ap-
roach in this difficult group of patients.
The most important factor for achieving favorable out-
ome with ECPR is the prompt establishment of adequate
rgan perfusion. Decision to institute ECMO support in
hildren who have not responded to traditional resuscitative
easures must be made early. At our hospital, we have
ABLE 2. Descriptive statistics for patients with favorable
nd unfavorable outcome after ECPR
Favorable
outcome
(n  24)
Unfavorable
outcome
(n  56)
P
value
ge (mo) 4.8 (0.6–16) 5.1 (0.9–29) .7
eight (kg) 5.2 (3.2–8.9) 5.2 (3.2–11.5) .9
ex
Female 29% 46% .2
Male 71% 54%
athology
Cardiac 96% 86% .2
Noncardiac 4% 14%
annulation site
Thoracic 50% 43% .6
Neck 50% 57%
CPR location
ICU 92% 88% .5
Cath lab 8% 7%
OR 0% 5%
CPR timing
Weekday 39% 30% .6
Weeknight 43% 44%
Weekend 17% 26%
natomy precluding
effective CPR
0% 5% .3
CMO exit by heart
transplantation
25% 2% .001
re-ECMO CPR
duration (min)
46 (29–55) 41 (30–55) .9
CMO duration (d) 4 (3–6) 4 (2–8.3) .9
ontinuous variables presented as median (25th quartile-75th quartile).
CPR, extracorporeal cardiopulmonary resuscitation; ICU, intensive care
nit; Cath lab, catheterization laboratory; OR, operating room; CPR,
ardiopulmonary resuscitation; ECMO, extracorporeal membrane
xygenation.dopted criteria to determine which patients are candidates c
56 The Journal of Thoracic and Cardiovascular Surgery ● Octoor ECPR. Those criteria include any child having a wit-
essed arrest, with lack of recovery of cardiac function
ithin 5 to 10 minutes of the initiation of CPR, and the
bsence of coexisting conditions that will preclude survival
r lifestyle such as pre-existing severe neurologic or genetic
nomaly or significant end-organ injury. Once the decision
s made, we aim to institute mechanical support within a
hort period of time (usually 25–40 minutes).
In this series, we reviewed different demographic and
linical variables aiming to identify those that significantly
ffect outcome.
PR Duration
e were unable to demonstrate a significant effect of the
uration of chest compressions before the institution of
CMO on survival or on the prevention of ischemic brain
njury. The duration of CPR was comparable between pa-
ients with favorable and unfavorable outcome. More im-
ortant, we identified 7 patients in whom chest compression
as performed for almost 1 hour before ECPR, up to a
aximum of 95 minutes, and who survived without any
ross neurologic deficit.
Most of the patients in this retrospective series had a
itnessed arrest with conventional CPR started immedi-
tely, especially the postcardiotomy group and other pa-
ients with cardiac disease who were closely monitored in
he hospital before their cardiac arrest; however, this anal-
sis may be contaminated by data from patients who had
rolonged arrest before initiation of CPR, for example, the
rowning child or other children with noncardiac disease,
nd that may explain the worse outcome in this group of
atients. Nonetheless, the important message is that in a
igure 1. Graph showing the relationship between the probability
f unfavorable outcome (death or stroke) as related to pre-ECMO
PR duration.hild with a witnessed arrest who received immediate and
ber 2007
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Ddequate resuscitation, we were unable to determine a CPR
uration beyond which ECMO support is futile. Similar to
ur experience, others have reported intact neurologic out-
omes in ECPR survivors after prolonged chest compres-
ion up to 176 minutes.2,14
The performance of effective CPR during the dissection
nd the cannulation stages is essential for good outcome.
hest compression is often interrupted for brief periods
uring neck dissection or cannulation. Similarly, if chest
annulation is performed, open heart massage may fre-
uently become compromised. Surgeons should avoid pro-
onged pauses in chest compression and should be able to
ake an early decision to change the cannula size or the
annulation site when having difficulties accessing the neck
essels. Unfortunately, the adequacy of chest compression
as hard to assess in this retrospective review, and identi-
ying patients who had poor resuscitation was not always
ossible. In a few anecdotal cases, inability to cannulate the
eck vessels resulted in frequent interruptions of conven-
ional CPR and a delay in establishment of ECMO and were
ssociated with poor neurologic outcomes.
Moreover, several factors can affect the quality of resus-
itation and oxygen delivery to the brain and other organs.
atients with blocked aortopulmonary shunts are at a high
isk for the development of ischemic brain injury despite
dequate blood pressure achieved with chest compressions.
n addition, 1 patient in our current series had a Fontan
onduit placed by the interventional cardiology service in
he catheterization laboratory, complicated by dislodgment
f the stented graft and cardiac arrest. Despite obtaining
dequate cardiac output with chest compression for a CPR
uration of 25 minutes until ECMO was initiated via neck
annulation, she had fatal irreversible ischemic brain injury
omplicating her cardiac arrest owing to the lack of ade-
uate blood flow and oxygen delivery to the brain. All 3
atients in our series with cardiac anatomy precluding ef-
ective augmentation of blood flow during CPR died of
schemic brain injury although that was not statistically
ignificant, likely owing to the small sample size.
CMO Duration
ultiple series in the literature showed that prolonged du-
ation of ECMO and the emergence of complications were
ll factors that have a significant negative impact on sur-
ival.11,12,19-21 The pattern of ECMO duration requirement
fter cardiac arrest is unique. Mechanical support was often
iscontinued early in the first 48 hours owing to the emer-
ence of irreversible ischemic brain injury or other severe
nd-organ injury such as lethal intestinal necrosis without
ny attempts to assess patients for cardiac recovery. On the
ther hand, similar to postcardiotomy ECMO, patients re-
uiring prolonged duration of ECMO with failure of cardiac
unction recovery are at high risk for the development of h
The Journal of Thoracicomplications such as intracranial hemorrhage, coagulopa-
hy, sepsis, and multiorgan system failure and will die
nless they undergo heart transplantation. The median du-
ation of ECMO in the favorable and unfavorable groups
as similar. However, that is likely due to the high inci-
ence of early withdrawal of support in those with severe
nd-organ injury after cardiac arrest.
After cardiac arrest and ECPR institution for postcar-
iotomy patients, prompt evaluation of any residual lesion
hat may require reintervention should be performed. In this
eries, 7 patients underwent reoperation to address their
esidual lesions, but only 1 infant survived with a favorable
utcome. This infant had complex second-stage reconstruc-
ion of single-ventricle disease complicated by severe cya-
osis and cardiac arrest requiring ECPR. She underwent
urgical revision with takedown of the bidirectional cavo-
ulmonary anastomosis and placement of a modified Bla-
ock–Taussig shunt.
If no residual lesions were present and the postcar-
iotomy patient continued to show no evidence of recovery
f cardiac function within an average of 72 hours, the
atient was assessed for candidacy to receive orthotopic
eart transplantation (OHTX). In our current series, OHTX
as often required for successful ECMO exit strategy.
mong all ECPR patients, 7 required OHTX with 6 survi-
ors and only 1 mortality owing to graft failure and unsuit-
bility of the patient for retransplantation.
nderlying Pathologic Conditions
e studied the influence of underlying pathologic condi-
ions on clinical outcome. Although the majority of patients
ad underlying cardiac disease, 9 children required ECPR
or the noncardiac problems listed in the Results section.
nly 1 neonate who had meconium aspiration syndrome
urvived, whereas the remaining 8 did not (89% mortality
ompared with 63%; P  .13) (Figure E3). This finding
ay be explainable by the presence of severe multiple organ
ysfunction in children with noncardiac conditions leading
o cardiac arrest and acknowledgement of the possibility
hat those children did not have a real witnessed arrest with
otential delays in initiation of CPR. Although the differ-
nce did not reach statistical significance, this may be due to
he small sample size. Similar to our findings, another large
eries from Philadelphia showed that children with isolated
eart disease were more likely to survive after ECPR than
ere children with a cardiac arrest complicating other med-
cal conditions.2
Seventy-one patients had underlying cardiac problems.
avorable outcomes were achieved in 50% of those with
ardiomyopathy, 67% of those with myocarditis, 36% of
hose having had cardiotomy, and 6% of patients with
noperated congenital heart disease. Although the likeli-
ood of recovery of cardiac function in myocarditis and
and Cardiovascular Surgery ● Volume 134, Number 4 957
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CH
Dome forms of cardiomyopathy probably increases their
hance of survival, the role of OHTX cannot be under-
stimated as a favorable exit strategy for appropriate
andidates.
ECMO support has been used successfully to salvage
eonates with a functional single ventricle from refractory
ow cardiac output syndrome postoperatively. In our series,
4% of postcardiotomy patients had single-ventricle pathol-
gy. Favorable outcome was achieved in 47% of those
atients compared with 27% of patients with 2-ventricle
athology. These results are encouraging and equivalent to
esults of ECMO support done in nonemergency settings in
atients with single ventricle.
tudy Limitations
ertain trends and anecdotes have been identified and may
ave affected outcome either positively (ability to offer
eart transplantation in cases of failure of cardiac recovery)
r negatively (unwitnessed arrest, noncardiac disease, fre-
uent pauses in chest compression, blocked shunts, prior
CMO during the same admission, and so on). Nonetheless,
his case series is subject to many limitations inherent in all
etrospective observational studies, such as selection bias
nd lack of randomization. Most important, there has been
o complete or uniform appraisal of neurologic function and
eficit by an independent pediatric neurology specialist.
inally, the small cohort size, the high incidence of patients
ith an unfavorable outcome, and the multiple variables in
his heterogeneous group of patients preclude sophisticated
tatistical analyses and limit the power of the study to
dentify clinically significant risk factors.
onclusions
CMO support of children with intractable cardiac arrest
an result in a favorable outcome in almost one third of the
atients. Acceptable survival and neurologic outcomes can
e achieved in children having prolonged cardiac arrest up
o 95 minutes. Heart transplantation is often needed for a
uccessful ECPR exit strategy. Timely application of me-
hanical support and judicious patient selection may be
ecessary for improved results. However, the lack of pre-
ictors for poor outcome supports aggressive attempts to
nitiate ECPR in patients with refractory cardiac arrest and
o comorbidities that severely limit their lifestyle or sur-
ival, followed by subsequent assessment of organ salvage
iven the extremely dismal outcome after prolonged con-
entional CPR in children with conditions refractory to
raditional interventions. Multi-institutional study with stan-
ardization of protocols and analysis of all variables may be
ecessary to achieve statistical power to determine signifi-
ant risk factors and to help establish useful selection guide-
ines for establishment of ECPR. Nonetheless, in this par-
icular case of ECPR, it might be difficult to carry out such
58 The Journal of Thoracic and Cardiovascular Surgery ● Octostudy with interpretable results from separate programs.
his is largely due to the large differences in manpower
vailability, the technical approaches to cannulation, and the
verall philosophy toward this type of support. Finally,
onsideration should be made toward expanding the appli-
ation of ECPR to the adult population. Adults may hold the
dvantages of having easier vascular access with the ability
o perform peripheral femoral cannulation without interrup-
ion of CPR. Finally, adult patients who survive the insult of
ardiac arrest can be offered various exit strategies, such as
ventricular assist device, as a longer-term bridge to recov-
ry or to transplantation that may be associated with im-
roved outcome.
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DFigure E1. Schematic diagram of the basic ECMO circuit used for ECPR at the Hospital for Sick Children (HSC) in
Toronto. *Quadrox D used with 3/8-inch circuit. ECMO, Extracorporeal membrane oxygenation; ECPR, extracorporeal
cardiopulmonary resuscitation.
Figure E2. A graph showing the duration of ECMO requirement for patients having favorable and unfavorable
outcome after ECPR. ECMO, Extracorporeal membrane oxygenation; ECPR, extracorporeal cardiopulmonary
resuscitation.59.e1 The Journal of Thoracic and Cardiovascular Surgery ● October 2007
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Alsoufi et al Surgery for Congenital Heart Diseaseigure E3. Time-related survival curves for ECPR patients strati-
ed by cardiac and noncardiac pathologic conditions. ECMO,
xtracorporeal membrane oxygenation; ECPR, extracorporeal
ardiopulmonary resuscitation.CH
DABLE E1. Multivariable logistic regression analysis using
ald statistics for unfavorable outcome (death or gross
eurologic injury) after ECPR
2 df P value
ge* 3.84 4 .4
ex 0.14 1 .7
eight* 3.55 4 .5
re-ECMO CPR duration* 2.47 2 .3
CPR timing 2.3 3 .5
annulation site 0.58 1 .5
CPR location 0.14 2 .9
natomy precluding effective CPR 0.01 1 .9
CPR, extracorporeal cardiopulmonary resuscitation; df, degrees of free-
om; ECMO, extracorporeal membrane oxygenation; CPR, cardiopulmonary
esuscitation. *Continuous variables modeled with a nonlinear transforma-
ion to account for lack of linearity. The P value presented is representative
f the overall effect.
The Journal of Thoracic aABLE E2. Multivariable Cox regression analysis using
ald statistics for time-related survival after ECPR
2 df P value
ge 0.16 1 .7
ex 1.61 1 .2
eight 0.03 1 .9
re-ECMO CPR duration 0.26 1 .6
annulation site 0.09 1 .8
natomy precluding effective CPR 3.39 1 .07
CPR, extracorporeal cardiopulmonary resuscitation; df, degrees of free-
om; ECMO, extracorporeal membrane oxygenation; CPR, cardiopulmonarynd Cardiovascular Surgery ● Volume 134, Number 4 959.e2
